Coastwise Capital Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
Coastwise Capital Group's GILD Position: Q2 2026 in Review
Coastwise Capital Group reduced its Gilead Sciences (GILD) stake by 21% in Q2 2026, selling an estimated $97.4K and leaving 2,707 shares worth $342K. The position accounts for 0.2% of the portfolio, ranked #102.
Coastwise Capital Group first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $724K in Q1 2025. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Coastwise Capital Group held 2,707 shares of Gilead Sciences worth $342K as of Q2 2026.
- Coastwise Capital Group sold 739 Gilead Sciences shares in Q2 2026, an estimated $97.4K.
- Gilead Sciences made up 0.2% of Coastwise Capital Group's portfolio in Q2 2026, its #102 holding.
- Coastwise Capital Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
- Coastwise Capital Group's Gilead Sciences position peaked at $724K in Q1 2025.
- 486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.